Dystrophic epidermolysis bullosa (DEB) is one of the main subtypes of epidermolysis bullosa, a group of genetic skin ...

Q1 2025 Earnings Call Transcript May 16, 2025 Operator: Good day and welcome to the Abeona Therapeutics First Quarter 2025 ...

Find out if gene therapy has also find its way into skin diseases. With two approvals in the last 2 years, is it the start of ...

ABEO READ THE FULL ABEO RESEARCH REPORT Business Update First Qualified Treatment Center Activated On May 14, 2025, Abeona ...

The FDA previously approved Jivi in 2018 to treat adults aged 12 years and older with hemophilia A. Treatment options for children with hemophilia A have expanded with the FDA approval of Bayer's ...

The FDA has responded to the increasing use of artificial intelligence (AI) in the discovery and development of drugs and biologics by publishing its first provisional guidance on the technology's ...

Rock West Composites (RWC) announces the publishing of engineering properties for most products and the launch of several calculators on its website for tubes and rods. This information will help ...

The FDA has released its recommendations on the composition of influenza vaccines for the 2025-26 season – without the input of its external advisors. The Vaccines and Related Biological ...

Northeast Delta Human Services Authority's research article, "The Assessment of Mental and Physical Health Outcomes Over Time in An Integrated Care Setting," will be published in BMC Primary Care ...

Recently, more patients became eligible for 177 Lu-PSMA-617. In March 2025, the U.S. Food and Drug Administration expanded approval so it can be used earlier in treatment. Previously, the FDA had ...